
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Geoffrey Richard, Stéphane Dalle, Marie‐Ambre Monet, et al.
EMBO Molecular Medicine (2016) Vol. 8, Iss. 10, pp. 1143-1161
Open Access | Times Cited: 110
Showing 1-25 of 110 citing articles:
Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion
José Pedro Friedmann Angeli, Dmitri V. Krysko, Marcus Conrad
Nature reviews. Cancer (2019) Vol. 19, Iss. 7, pp. 405-414
Closed Access | Times Cited: 991
José Pedro Friedmann Angeli, Dmitri V. Krysko, Marcus Conrad
Nature reviews. Cancer (2019) Vol. 19, Iss. 7, pp. 405-414
Closed Access | Times Cited: 991
RAS-targeted therapies: is the undruggable drugged?
Amanda R. Moore, Scott Rosenberg, Frank McCormick, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 8, pp. 533-552
Open Access | Times Cited: 819
Amanda R. Moore, Scott Rosenberg, Frank McCormick, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 8, pp. 533-552
Open Access | Times Cited: 819
Dynamic EMT: a multi‐tool for tumor progression
Simone Brabletz, Harald Schuhwerk, Thomas Brabletz, et al.
The EMBO Journal (2021) Vol. 40, Iss. 18
Open Access | Times Cited: 504
Simone Brabletz, Harald Schuhwerk, Thomas Brabletz, et al.
The EMBO Journal (2021) Vol. 40, Iss. 18
Open Access | Times Cited: 504
Non-redundant functions of EMT transcription factors
Marc P. Stemmler, Rebecca L. Eccles, Simone Brabletz, et al.
Nature Cell Biology (2018) Vol. 21, Iss. 1, pp. 102-112
Closed Access | Times Cited: 461
Marc P. Stemmler, Rebecca L. Eccles, Simone Brabletz, et al.
Nature Cell Biology (2018) Vol. 21, Iss. 1, pp. 102-112
Closed Access | Times Cited: 461
Cellular plasticity and the neuroendocrine phenotype in prostate cancer
Alastair Davies, Himisha Beltran, Amina Zoubeidi
Nature Reviews Urology (2018) Vol. 15, Iss. 5, pp. 271-286
Closed Access | Times Cited: 356
Alastair Davies, Himisha Beltran, Amina Zoubeidi
Nature Reviews Urology (2018) Vol. 15, Iss. 5, pp. 271-286
Closed Access | Times Cited: 356
Cancer stem cells: The root of tumor recurrence and metastases
Claudia Peitzsch, Anna Tyutyunnykova, Klaus Pantel, et al.
Seminars in Cancer Biology (2017) Vol. 44, pp. 10-24
Closed Access | Times Cited: 350
Claudia Peitzsch, Anna Tyutyunnykova, Klaus Pantel, et al.
Seminars in Cancer Biology (2017) Vol. 44, pp. 10-24
Closed Access | Times Cited: 350
Phenotype plasticity as enabler of melanoma progression and therapy resistance
Imanol Arozarena, Claudia Wellbrock
Nature reviews. Cancer (2019) Vol. 19, Iss. 7, pp. 377-391
Open Access | Times Cited: 326
Imanol Arozarena, Claudia Wellbrock
Nature reviews. Cancer (2019) Vol. 19, Iss. 7, pp. 377-391
Open Access | Times Cited: 326
Pleiotropic Roles for ZEB1 in Cancer
Julie Caramel, Maud Ligier, Alain Puisieux
Cancer Research (2017) Vol. 78, Iss. 1, pp. 30-35
Closed Access | Times Cited: 276
Julie Caramel, Maud Ligier, Alain Puisieux
Cancer Research (2017) Vol. 78, Iss. 1, pp. 30-35
Closed Access | Times Cited: 276
ZEB1: A Critical Regulator of Cell Plasticity, DNA Damage Response, and Therapy Resistance
Stanislav Drápela, Jan Bouchal, Mohit Kumar Jolly, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 143
Stanislav Drápela, Jan Bouchal, Mohit Kumar Jolly, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 143
Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-dependent mechanism
Susana García‐Silva, Alberto Benito‐Martín, Laura Nogués, et al.
Nature Cancer (2021) Vol. 2, Iss. 12, pp. 1387-1405
Open Access | Times Cited: 127
Susana García‐Silva, Alberto Benito‐Martín, Laura Nogués, et al.
Nature Cancer (2021) Vol. 2, Iss. 12, pp. 1387-1405
Open Access | Times Cited: 127
Cancer plasticity in therapy resistance: Mechanisms and novel strategies
Xing Niu, Wenjing Liu, Zhang Yinling, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101114-101114
Closed Access | Times Cited: 16
Xing Niu, Wenjing Liu, Zhang Yinling, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101114-101114
Closed Access | Times Cited: 16
Epithelial–mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer?
Jente van Staalduinen, D.A. Baker, Peter ten Dijke, et al.
Oncogene (2018) Vol. 37, Iss. 48, pp. 6195-6211
Closed Access | Times Cited: 154
Jente van Staalduinen, D.A. Baker, Peter ten Dijke, et al.
Oncogene (2018) Vol. 37, Iss. 48, pp. 6195-6211
Closed Access | Times Cited: 154
The roles of ZEB1 in tumorigenic progression and epigenetic modifications
Yu Zhang, Lei Xu, Anqi Li, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 110, pp. 400-408
Open Access | Times Cited: 128
Yu Zhang, Lei Xu, Anqi Li, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 110, pp. 400-408
Open Access | Times Cited: 128
Transdermal Gene Delivery by Functional Peptide-Conjugated Cationic Gold Nanoparticle Reverses the Progression and Metastasis of Cutaneous Melanoma
Jie Niu, Yang Chu, Yanfen Huang, et al.
ACS Applied Materials & Interfaces (2017) Vol. 9, Iss. 11, pp. 9388-9401
Closed Access | Times Cited: 113
Jie Niu, Yang Chu, Yanfen Huang, et al.
ACS Applied Materials & Interfaces (2017) Vol. 9, Iss. 11, pp. 9388-9401
Closed Access | Times Cited: 113
Mechanisms of Acquired BRAF Inhibitor Resistance in Melanoma: A Systematic Review
Ilaria Proietti, Nevena Skroza, Nicoletta Bernardini, et al.
Cancers (2020) Vol. 12, Iss. 10, pp. 2801-2801
Open Access | Times Cited: 103
Ilaria Proietti, Nevena Skroza, Nicoletta Bernardini, et al.
Cancers (2020) Vol. 12, Iss. 10, pp. 2801-2801
Open Access | Times Cited: 103
Human melanocyte development and melanoma dedifferentiation at single-cell resolution
R.L. Belote, Daniel Le, Ashley Maynard, et al.
Nature Cell Biology (2021) Vol. 23, Iss. 9, pp. 1035-1047
Open Access | Times Cited: 94
R.L. Belote, Daniel Le, Ashley Maynard, et al.
Nature Cell Biology (2021) Vol. 23, Iss. 9, pp. 1035-1047
Open Access | Times Cited: 94
EMT-Inducing Transcription Factors, Drivers of Melanoma Phenotype Switching, and Resistance to Treatment
Yaqi Tang, Simon Durand, Stéphane Dalle, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2154-2154
Open Access | Times Cited: 75
Yaqi Tang, Simon Durand, Stéphane Dalle, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2154-2154
Open Access | Times Cited: 75
ZEB1 transcription factor promotes immune escape in melanoma
Maud Plaschka, Valentin Benboubker, Maxime Grimont, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 3, pp. e003484-e003484
Open Access | Times Cited: 57
Maud Plaschka, Valentin Benboubker, Maxime Grimont, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 3, pp. e003484-e003484
Open Access | Times Cited: 57
The low affinity neurotrophin receptor CD271 regulates phenotype switching in melanoma
Gaetana Restivo, Johanna Diener, Phil F. Cheng, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 72
Gaetana Restivo, Johanna Diener, Phil F. Cheng, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 72
Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype
Tobias Sinnberg, Mitchell P. Levesque, Jelena Krochmann, et al.
Molecular Cancer (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 69
Tobias Sinnberg, Mitchell P. Levesque, Jelena Krochmann, et al.
Molecular Cancer (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 69
MITF-High and MITF-Low Cells and a Novel Subpopulation Expressing Genes of Both Cell States Contribute to Intra- and Intertumoral Heterogeneity of Primary Melanoma
Marie Ennen, Céline Keime, Giovanni Gambi, et al.
Clinical Cancer Research (2017) Vol. 23, Iss. 22, pp. 7097-7107
Open Access | Times Cited: 62
Marie Ennen, Céline Keime, Giovanni Gambi, et al.
Clinical Cancer Research (2017) Vol. 23, Iss. 22, pp. 7097-7107
Open Access | Times Cited: 62
Histone Deacetylase Inhibitors to Overcome Resistance to Targeted and Immuno Therapy in Metastatic Melanoma
Minjeong Yeon, Youngmi Kim, Hyun Suk Jung, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 53
Minjeong Yeon, Youngmi Kim, Hyun Suk Jung, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 53
The role of CAF derived exosomal microRNAs in the tumour microenvironment of melanoma
M. Shelton, Chinedu Anthony Anene, Jérémie Nsengimana, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1875, Iss. 1, pp. 188456-188456
Open Access | Times Cited: 52
M. Shelton, Chinedu Anthony Anene, Jérémie Nsengimana, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1875, Iss. 1, pp. 188456-188456
Open Access | Times Cited: 52
Melanoma Plasticity: Promoter of Metastasis and Resistance to Therapy
Fan Huang, François Santinon, Raúl Ernesto Flores González, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 42
Fan Huang, François Santinon, Raúl Ernesto Flores González, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 42
The Fra-1/AP-1 Oncoprotein: From the “Undruggable” Transcription Factor to Therapeutic Targeting
Laura Casalino, Francesco Talotta, Amelia Cimmino, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1480-1480
Open Access | Times Cited: 34
Laura Casalino, Francesco Talotta, Amelia Cimmino, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1480-1480
Open Access | Times Cited: 34